Faculté des Sciences Pharmaceutiques et Biologiques
Cibles Thérapeutiques et Conception du Médicament (CiTCoM)
4 av. de l'Observatoire
75270 Paris Cedex 06
Directeur de l'unité de rattachement : : Nicolas LEULLIOT
VIDAL Michel | |
---|---|
Courriel : michel.vidalSPAMFILTER@u-paris.fr | Tel: 01 53 73 15 64 |
Guedes IA, Barreto AMS, Marinho D, Krempser E, Kuenemann MA, Sperandio O, Dardenne LE, Miteva MA. New machine learning and physics-based scoring functions for drug discovery. Sci Rep. 2021 Feb 4;11(1):3198. doi: 10.1038/s41598-021-82410-1.
Noé G, Bellesoeur A, Golmard L, Thomas-Schoemann A, Boudou-Rouquette P, Tiako Meyo M, Puszkiel A, Arrondeau J, Alexandre J, Goldwasser F, Blanchet B, Vidal M. Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab. Cancers (Basel). 2019 May 31;11(6). pii: E762
Wang L., Zhou L., Reille-Seroussi M., Gagey-Eilstein N., Broussy S., Ji L., Vidal M. Liu WQ. Identification of peptidic antagonists of vascular endothelial growth factor receptor-1 by scanning the binding epitopes of its ligands. J Med Chem, 2017 ;60(15):6598-6606.
Reille-Seroussi M., Gaucher JF., Cussac LA., Broutin I., Vidal M., Broussy S. VEGFR1 domain 2 covalent labeling with horseradish peroxidase: Development of a displacement assay on VEGF. Anal. Biochem. 2017, 530, 107-112.
Tourteau A., Bontemps A., Merlet E., Leland M., Helissey P., Giorgi-Renault S., Desbène-Finck S. Easy acces to 1H-pyrrolo[3’,4’: 5,6]pyrido[2,3-d]pyrimidine-2,4,6,8(3H,7H)-tetraone and selectively N7-substituted analogues via key synthons. Eur. J. Org. Chem. 2015, 32, 7028-7035.